JULIAN GANGOLLI
Profile
First Name
: JULIAN
Middle Name
:
Last Name
: GANGOLLI
Related Companies
Titles
Company Name
Related People
DIRECTOR
GERD AUFFARTH, KENNETH M. BAHRT, TODD BRADY, TODD C. BRADY, SCOTT CANUTE, TERRY DAGNON, ALBERT D. DYRNESS, JEFF EVANSON, SCOTT A. GANGLOFF, DONALD GRIFFITH, DONALD J. GRIFFITH, YEZAN HADDADIN, JULIA A. HALLER, KURT J. HILZINGER, ROBIN HOKE, ANDONG HUANG, LAWRENCE KENYON, LAWRENCE A. KENYON, STEPHEN J. MCANDREW, PANKAJ MOHAN, FAISAL G. SUKHTIAN, JOE THOMAS, RANDY THURMAN, RANDY H. THURMAN, C. RUSSELL TRENARY, ELIZABETH YAMASHITA
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2026-04-23
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-01-17
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2024-04-15
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2024-03-18
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2022-12-28
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2022-12-28
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-02-03
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-06-02
